Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

Last week, the industry was energized by the Drug Enforcement Administration’s order placing certain drugs containing cannabidiol, or CBD, in Schedule V of the Controlled Substances Act. Under the CSA, CBD remains a Schedule I substance, which means that it is not considered to have any currently accepted medical use.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Veriheal

DECEMBER 28, 2021

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. This, researchers say, makes CBD a top choice for relieving the symptoms of neurodegenerative disorders like Alzheimer’s and PTSD.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Alchimia

APRIL 17, 2018

While further research is needed in both humans and animals, cannabinoids like CBD are being increasingly used to treat diverse symptoms and pains in pets , since many users have realised the great benefits it can provide in some cases. CBD oils and extracts are made from organic hemp crops. Benefits of CBD for pets.

Pets 75

Pets CBD Cannabinoids Terpenes 75

CannaMD

NOVEMBER 20, 2020

a wealth of new research legitimizing marijuana’s role in patient care – here we are. Making matters worse, there’s only one farm in the entire country with DEA approval to cultivate marijuana for research purposes. For more details, see: CBD May Improve Workplace Performance. Cannabis vs. Opioids. More Cannabis.

Therapy 79

Therapy Treatment DEA CBD 79

SpeedWeed

AUGUST 8, 2021

If all goes according to plan, patients will receive Sativex and the temozolomide chemotherapy drug, temozolomide on its own, or a placebo. In 2018, the CBD and Delta-9-THC oral aerosol spray became the first FDA-approved drug derived from marijuana. That’s how much money it will take to pull the project off. View original article.

Cannabinoids 64

Cannabinoids Pharmaceutical DEA Medicine 64

Weedistry

MARCH 7, 2019

Guzman administered pure THC via a catheter into the tumors of nine hospitalized patients with glioblastoma, who had failed to respond to standard brain-cancer therapies. He postulates that CBD , by virtue of its ability to silence ID -1 expression, could be a breakthrough anti-cancer medication.

THC 40

THC CBD Clinical Trials Research and Development 40

Veriheal

MAY 6, 2022

Millions of post-traumatic stress disorder (PTSD) patients around the world—such as ex-veterans and military servicemen—tend to relive their traumatic flashbacks and experiences during sleep. Does CBD Impact REM Sleep? Interestingly, research shows that CBD may influence REM sleep, albeit in dose-dependent quantities.

Sleep 98

Sleep Cannabinoids THC CBD 98

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. The governor also signed Senate Bill 1700 to protect the privacy of doctors recommending low-THC marijuana and their patients.

Law 126

Law Marijuana Patients Treatment 126

Veriheal

NOVEMBER 11, 2023

According to the United States Drug Enforcement Administration (DEA), Schedule One drugs are “drugs with no currently accepted medical use and a high potential for abuse.” However, cannabidiol (CBD) and CBD products obtained from hemp plants with less than 0.3% Additionally, seven US states allow the medical use of CBD oil.

Law 62

Law Chronic Pain Conditions Legislation 62

The Blunt Truth

OCTOBER 3, 2019

They maintain that the limits will put constraints on the amount of marijuana available to patients. In Connecticut , meanwhile, the state may add chronic pain to the list of conditions eligible for treatment with medical marijuana. Note that McConnell still refers to marijuana as hemp’s “illicit cousin.”

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

Veriheal

AUGUST 31, 2020

Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Nishtha Tripathi. Program between St.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 23, 2021

Both notices state most of the delta-8 THC products on the market have been “synthetically converted” from CBD but fail to address the fundamental stakeholder question as to the legality of these products. Delta-8 THC products should be kept out of the reach of children and pets. Should be stored away from children.

THC 52

THC Concentrates Pets DEA 52

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. Another group received an 11% CBD product with minimal THC.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. Because of the ambiguity in our law, I learned that many veterinarians chose not to talk about CBD with pet owners for fear of being disciplined,” Yeager said. Earlier this year, Gov. A simple question.

Patients 105

Patients Pets Seed-To-Sale Cannabinoids 105

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. FTC issues three CBD warning letters, reiterating that established FTC substantiation standards apply when advertisers make health-related representations for CBD products. The state has issued 8,000 patient and caregiver ID cards since June 28. Hemp / CBD.

Vaping 40

Vaping Banking Research and Development DEA 40

CannaMD

SEPTEMBER 10, 2020

As medical marijuana becomes more readily available, it has become an increasingly popular option for the treatment of nausea and morning sickness during pregnancy. A physician may not issue a physician certification, except for low-THC cannabis, to a patient who is pregnant. Find Out if You Qualify. Get Started. Join 55K+ Subscribers!

Marijuana 59

Marijuana Therapy Data THC 59

Canna Law Blog

SEPTEMBER 28, 2019

Not long ago we wrote about a decision by the Second Circuit that may force the DEA to re- or deschedule marijuana after writing about the lawsuit when it was first filed last year. Student visited the emergency room frequently when these were the only medical treatments she took. From immigration to waste dumping.

Education 64

Education Oil DEA Cannabis 64

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. The partnership will initiate the development of CBD and THC oral thin films for CURE’s clinical studies targeted at advancing veteran health.

DEA 59

DEA Pharmaceutical Research and Development Compliance 59

Cannabis Law Report

JUNE 10, 2021

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

SpeedWeed

MARCH 28, 2021

That’s what most providers are worried about when their patients with PTSD decide to try cannabis.”. As a result, there has been more interest among patients, clinicians, and researchers to see if cannabis is effective in treating PTSD. . Groups were each given a strain consisting of 9% THC, 11% CBD, or 8% THC/8% CBD. .

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

CannaMD

NOVEMBER 15, 2020

His findings are sure to alarm medical cannabis professionals and patients alike. research on marijuana harms – such as cannabis withdrawal, treatments for substance abuse and use/exposure during pregnancy or infancy – received 20 times more funding than research on cannabis therapeutics. funders use their money for cannabis research.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

Cannabis Law Report

SEPTEMBER 23, 2019

Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. Relevant AAFP Policy. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

SEPTEMBER 12, 2021

The other two types either have a balanced ratio of the non-intoxicating CBD and THC (Type II), or a high ratio of CBD with only trace amounts of THC (Type III). THC vs CBD. Both THC and CBD are chemically very similar, but act extremely differently in the body (Shutterstock). What is THC?

THC 98

THC Research and Development Cannabinoids CBD 98

The Cannigma

MAY 6, 2021

Roughly 150 different cannabinoids have been identified already, but the two most common and abundant are delta-9- THC and CBD. Delta-9-THC and CBD can be found in concentrations as high as 20% and even 30%, but minor cannabinoids such as delta-8-THC generally occur in concentrations below 1%. How delta-8-THC is made.

THC 145

THC Cannabinoids Concentrates Hemp 145

The Cannigma

FEBRUARY 16, 2022

So, if you’re interested in growing your own cannabis, whether it’s to make CBD hemp oil or whether it’s to burn one down after work, definitely check out our articles and you’ll learn something and maybe it’ll even be from Steven. Then CBD popped up in 2018 with the Farm Bill, right? SP: Yeah, for sure.

Trichome 78

Trichome Wellness and Beauty Cannabinoids Cannabis 78

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Traditional plant extracts contain many compounds in addition to THC and CBD that contribute to the medical benefits of cannabis.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

MARCH 21, 2019

Is CBD legal in all 50 states? Do I need a prescription in order to consume CBD? In this article I’m going to update you on the legal status of CBD , and only CBD, in the United States. What is CBD? CBD is completely non-psychoactive. Is CBD Legal Under Federal Law? Is CBD Legal in all 50 States?

State Laws 55

State Laws Law CBD Legalization 55

The Herb Collective

MARCH 30, 2018

CBD, a compound of marijuana, is being researched as an alternative to opioids for chronic pain and opiate addiction. The interesting thing about CBD is that it doesn’t get you high. Unfortunately, CBD is still labeled as high potential for abuse by the DEA. All these are great benefits of CBD.

Chronic Pain 40

Chronic Pain DEA Wellness and Beauty Marijuana 40

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. The governor of Alabama signed a recreational bill into law in 2021, but patients will likely not have access to retail products until 2022.

Recreational 52

Recreational Data Cannabis DEA 52

SpeedWeed

JUNE 15, 2021

Rather than going head-to-head with other well-funded competitors in some US state auction while facing down the DEA or buying out a patient collective or two in Canada, the process was a bit simpler. This is actually nothing new in the British treatment of cannabis. It came into existence in a rather unique way.

Pharmaceutical 40

Pharmaceutical Chronic Pain Epilepsy Patients 40

SpeedWeed

DECEMBER 28, 2018

Bummer: The Cost of Legal CBD. It was fast tracked through the approval process in response to parents of severely epileptic children pushing for a way to legally use CBD, after seeing it work wonders for children profiled in a 2013 CNN documentary called Weed , hosted by Dr. Sanjay Gupta. RELATED STORY.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 30, 2019

The informed patients, cannabis industry employees, and clinicians find it equally difficult to keep updated on Florida’s latest medical marijuana program news and changes. . In light of all this state cannabis information overload, what are some of the reasons a patient ultimately chooses a qualified personal cannabis physician? .

Marijuana 45

Marijuana Patients Research and Development Programs 45

NewsMunchies

SEPTEMBER 5, 2018

A new marijuana-derived drug to treat rare forms of severe epilepsy in children will cost about $32,500 per patient, per year. Food and Drug Administration (DEA), contains the active ingredient cannabidiol (CBD) but it does not contain psychoactive molecule THC, which generates the marijuana high. “We

Supply Chain 40

Supply Chain DEA Pharmaceutical Chronic Pain 40